Cataract Online Refraction Evaluation: A Multi Center Randomized Controlled Trial (CORE-RCT)

May 31, 2023 updated by: Robert P.L. Wisse, MD PhD, UMC Utrecht

Background of the study:

Cataract is widely prevalent in especially elderly and cataract extraction surgery has thus become one of the most performedsurgeries worldwide. In recent decades the safety of cataract surgery has greatly improved and it is considered one of the safestsurgeries to be performed. Postoperative management consists of routine examinations within one week, to ascertain no adverseevents have occurred immediately after surgery, and between 4-6 weeks, to determine the refractive error. The incidence of seriousadverse events following cataract surgery is estimated to be 1%. As a result, the majority of patient visits after cataract surgery willbe uneventful. Nonetheless valuable time and hospital resources are consumed. Remote monitoring could replace clinicalexaminations in selected patient groups. However, this practice of digital remote monitoring which the patient can use independentlyhas not been clinically validated yet.

Objective of the study:

To determine non-inferiority of the corrected distance visual acuity (CDVA) with the prescription obtained through the web-basedmeasurement of refractive error, compared to usual care, in patients who underwent routine cataract surgery.

Study design:

Observational randomized trial without interventions

Study population:

Patients eligible for cataract surgery, without visual acuity influencing comorbidities or predisposing complicating factors.

Primary study parameters/outcome of the study:

costeffectiveness

Secundary study parameters/outcome of the study (if applicable):

Corrected distance visual acuity at the final post-operative visit, uncorrected distance visual acuity, refractive error(sphere/cylinder/axes), patient reported outcome measurements, adverse events.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Actual)

94

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vienna, Austria
        • Vienna Institute for Research in Ocular Surgery, Austria
      • Sulzbach, Germany
        • Augenklink Sulzbach
      • Maastricht, Netherlands
        • Maastricht UMC+
      • Utrecht, Netherlands, 3508 GA
        • Janneau Claessens
    • Noord-Brabant
      • Breda, Noord-Brabant, Netherlands, 4818CK
        • Amphia ziekenhuis
    • Noord-Holland
      • Heerhugowaard, Noord-Holland, Netherlands, 1704 AG
        • Oogcentrum Noordholland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Planned for bilateral phacoemulsification cataract extraction and intra-ocular lens implantation (either sequentialor in one procedure)
  • ≥ 18 years of age
  • No other current ophthalmic conditions or history that negatively influence post-operative visual acuity
  • Be able to fill out the health questionnaires (in Dutch, German or English) and perform the web-based refractiveassessment (possibly with assistance of family member or other close relative).
  • Specific digital requirements include access to a computer and a smartphone and knowledge how to log in to anonline patient portal.

Exclusion Criteria:

  • Cataract extraction surgery combined with other procedures, including: keratoplasty, vitrectomy, glaucoma filter implants
  • Ocular comorbidities that negatively influence post-operative visual acuity
  • No access to the digital requirements to take the online health questionnaire and/or perform the online refraction.
  • Insufficient command of the Dutch, German or English language to understand the questionnaires andinstructions of the web-based refractive assessment or no family member / close relative to assist with this
  • Inability of performing the web-based eye exam prior to cataract surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Telemonitoring
Subjects in the telemonitoring group will have post-operative follow-up measurements involving teleconsultations, remote eye exams and health questionnaires.
remote monitoring after cataract surgery
No Intervention: Usual care
Subjects in the usual care group will receive regular post-operative care, mostly involving in-hospital consultations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost-effectiveness
Time Frame: pre-operative until 3 months after surgery
The main outcome measure will be Incremental cost-effectiveness ratio (ICER), defined as euros per QALY, and compared between the two groups.
pre-operative until 3 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Corrected distance visual acuity at the final post-operative visit (achieved with web-based vs manifest refraction)
Time Frame: 4-6 weeks after surgery
The corrected distance visual acuity achieved with the web-based refraction will be compared to the corrected distance visual acuity that is achieved with the subjective refraction.
4-6 weeks after surgery
Uncorrected distance visual acuity (web-based vs reference chart)
Time Frame: pre-operative, 4-6 weeks after surgery
The uncorrected distance visual acuity that is assessed in the web-based assessment will be compared to the uncorrected distance visual acuity that is assessed using the reference chart.
pre-operative, 4-6 weeks after surgery
Refractive error in sphere/cylinder/axes (web-based vs reference chart)
Time Frame: 4-6 weeks after surgery
The refractive error (in sphere/cylinder/axes) will be asssessed by the web-based assessment and compared to the subjective refractive error assessment.
4-6 weeks after surgery
Patient reported outcomes
Time Frame: pre-operative vs 3 months after surgery
The PROMs questionnaire (CatQuest-9SF) assesses the patient's own reported visual disability from cataract and the improvement after surgery. High scores represent better visual acuity. The results of the PROMs questionnaire will be compared between the groups to assess differences and determine if a web-based follow-up strategy influences these subjective measures. PROMs will be offered in Dutch, German or English accordingly and assessed at baseline and at 3 months follow-up.
pre-operative vs 3 months after surgery
Adverse events / additional consultations
Time Frame: pre-operative until 3 months after surgery
All unplanned additional consultations (telephone or hospital) will be recorded. We will count these and compare the frequencies between the two groups.
pre-operative until 3 months after surgery
Total costs
Time Frame: pre-operative until 3 months after surgery
Total costs (in euros) will be determined for both groups. We will count costs for hospital resources and staff, as well as costs for the patient (such as travel and parking costs).
pre-operative until 3 months after surgery
QALY's
Time Frame: pre-operative and 3 months after surgery
To determine the QALY, patients of both groups will be requested to fill out questionnaires to assess quality of life (EQ-5D). A unique health state is defined by combining one level from each of the five dimensions. Higher levels indicate more problems.
pre-operative and 3 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 19, 2021

Primary Completion (Actual)

May 10, 2023

Study Completion (Estimated)

July 22, 2023

Study Registration Dates

First Submitted

March 10, 2021

First Submitted That Met QC Criteria

March 18, 2021

First Posted (Actual)

March 22, 2021

Study Record Updates

Last Update Posted (Actual)

June 1, 2023

Last Update Submitted That Met QC Criteria

May 31, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NL74625.041.20

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on remote monitoring after cataract surgery

Subscribe